Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
166.74%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$1.11 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total liabilities are S$1.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Arrowhead Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30S$1.21 B86.56%
2023-09-30S$0.65 B66.41%
2022-09-30S$0.39 B-4.04%
2021-09-30S$0.40 B393.87%
2020-09-30S$82.87 M-43.34%
2019-09-30S$0.14 B553.43%
2018-09-30S$22.38 M-28.88%
2017-09-30S$31.47 M-30.42%
2016-09-30S$45.23 M40.3%
2015-09-30S$32.23 M50.11%
2014-09-30S$21.47 M47.56%
2013-09-30S$14.55 M53.41%
2012-09-30S$9.48 M119.69%
2011-09-30S$4.31 M-23.23%
2010-09-30S$5.62 M39.71%
2009-09-30S$4.02 M-43.43%
2008-09-30S$7.11 M41.94%
2007-09-30S$5.01 M8.12%
2006-09-30S$4.63 M167.92%
2005-09-30S$1.73 M49.31%
2004-09-30S$1.15 M597.28%
2003-09-30S$0.16 M-94.21%
2002-09-30S$2.86 M20.34%
2001-09-30S$2.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alnylam Pharmaceuticals
ALNY
S$5.98 B 436.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.68 B-38.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S$99.92 M-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.13 B 13,089.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$3.63 B 225.86%๐Ÿ‡บ๐Ÿ‡ธ USA